» Articles » PMID: 26578880

The Established and Emerging Roles of Astrocytes and Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Overview
Specialty Cell Biology
Date 2015 Nov 19
PMID 26578880
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two progressive, fatal neurodegenerative syndromes with considerable clinical, genetic and pathological overlap. Clinical symptoms of FTD can be seen in ALS patients and vice versa. Recent genetic discoveries conclusively link the two diseases, and several common molecular players have been identified (TDP-43, FUS, C9ORF72). The definitive etiologies of ALS and FTD are currently unknown and both disorders lack a cure. Glia, specifically astrocytes and microglia are heavily implicated in the onset and progression of neurodegeneration witnessed in ALS and FTD. In this review, we summarize the current understanding of the role of microglia and astrocytes involved in ALS and FTD, highlighting their recent implications in neuroinflammation, alterations in waste clearance involving phagocytosis and the newly described glymphatic system, and vascular abnormalities. Elucidating the precise mechanisms of how astrocytes and microglia are involved in ALS and FTD will be crucial in characterizing these two disorders and may represent more effective interventions for disease progression and treatment options in the future.

Citing Articles

Association of cortical morphology, white matter hyperintensity, and glymphatic function in frontotemporal dementia variants.

Xiao D, Li J, Ren Z, Dai M, Jiang Y, Qiu T Alzheimers Dement. 2024; 20(9):6045-6059.

PMID: 39129270 PMC: 11497707. DOI: 10.1002/alz.14158.


Preliminary Analysis of Potentially Overlapping Differentially Expressed Proteins in Both the Spinal Cord and Brain of SOD1 G93A Mice.

Jiang S, Jiang S, Nie H, Nie H, Hua S, Xie M Curr Protein Pept Sci. 2024; 26(1):57-75.

PMID: 38984582 DOI: 10.2174/0113892037293525240621120033.


Kinetic modeling of the monoamine oxidase-B radioligand [F]SMBT-1 in human brain with positron emission tomography.

Lopresti B, Stehouwer J, Reese A, Mason N, Royse S, Narendran R J Cereb Blood Flow Metab. 2024; 44(11):1262-1276.

PMID: 38735059 PMC: 11542143. DOI: 10.1177/0271678X241254679.


Molecular hallmarks of ageing in amyotrophic lateral sclerosis.

Jagaraj C, Shadfar S, Kashani S, Saravanabavan S, Farzana F, Atkin J Cell Mol Life Sci. 2024; 81(1):111.

PMID: 38430277 PMC: 10908642. DOI: 10.1007/s00018-024-05164-9.


Radiation-induced glymphatic dysfunction in patients with nasopharyngeal carcinoma: a study using diffusion tensor image analysis along the perivascular space.

Zheng X, Peng J, Zhao Q, Li L, Gao J, Zhou K Front Neurosci. 2024; 17:1321365.

PMID: 38343708 PMC: 10853370. DOI: 10.3389/fnins.2023.1321365.


References
1.
Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund S . VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 2003; 34(4):383-94. DOI: 10.1038/ng1211. View

2.
Dickson D, Kouri N, Murray M, Josephs K . Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J Mol Neurosci. 2011; 45(3):384-9. PMC: 3208128. DOI: 10.1007/s12031-011-9589-0. View

3.
Migheli A, Piva R, Atzori C, Troost D, Schiffer D . c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1997; 56(12):1314-22. DOI: 10.1097/00005072-199712000-00006. View

4.
Bi F, Huang C, Tong J, Qiu G, Huang B, Wu Q . Reactive astrocytes secrete lcn2 to promote neuron death. Proc Natl Acad Sci U S A. 2013; 110(10):4069-74. PMC: 3593910. DOI: 10.1073/pnas.1218497110. View

5.
Zhu G, Wu C, Zhao Y, Ashwell J . Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr Biol. 2007; 17(16):1438-43. DOI: 10.1016/j.cub.2007.07.041. View